Individual InvestorsEmployee Shareholders Institutional InvestorsPrivate Companies Accredited InvestorsSeed & Angel InvestorsAsset Managers & Hedge FundsFamily OfficesVenture Capital FirmsWealth Managers & RIAsWho We Serve Trading Data Liquidity Programs Retirement Individual InvestingForge MarketplaceFind new private company investment opportunities​Browse CompaniesInstitutional TradingForge ProTrade private companies with Forge’s institutional brokerage tool​Forge PriceA proprietary indicative price, calculated daily, for approximately 200 pre-IPO companiesForge DataAnalyze private markets via Forge’s intuitive web application​Forge Private Market Index​Monitor a benchmark for actively traded private companies ​Forge Accuidity Private Market Index​Invest in an institutionally-managed diversified basket of private companies (QPs only)​Liquidity ProgramsRetain and reward employees with company-sponsored liquidity solutions like tender offers and customized programsSelf-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRAWhat We Do All insights Reports and highlights News and trends Private market education Tips and tutorials Forge Investment OutlookPrivate Market UpdatesIPO calendarPrivate Magnificent 7Emerging trendsPrivate company newsUpcoming IPOsAll guidesPrivate market basicsPrivate shares transactionsValuations, pricing and market trendsSelling in the private marketFAQsGlossaryCompany page and tradesProof of ownershipBid and ask submissionsForge fund offeringsInsights About UsLeadershipPeople & CultureCareers About
Log InSign Up
Who We Serve
What We Do
Insights
About
Who We Serve
Individual Investors
Institutional Investors
What We Do
Trading
Individual Investing
Institutional Trading
Data
Liquidity Programs
Retirement
Self-Directed IRA
Insights
Reports and highlights
News and trends
Private market education
Tips and tutorials
About
Log In
Sign Up
Secondary marketplace / Trade private companies

Browse Biotech & Pharma Companies

Biotech focuses on infusing biological processes with technology to improve human, animal, and environmental health. Biotech & Pharma businesses utilize technology to work toward disease prevention, treatment and cure. These businesses also work in Agtech and fuel development. Register today to discover how Forge can help you buy and sell private shares.

Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.

Register
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Less than $500MM
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Filters (3)
More (3)
Healthcare
All Consumer & Lifestyle Education Energy Enterprise Software Fintech Foodtech Healthcare Industrial Real Estate Technology Hardware Transportation
Biotech & Pharma
All Biotech & Pharma Digital Health Healthcare Providers & Services Healthcare Software Medical Devices Other Healthcare
Less than $500MM
All Less than $500MM $500MM to $1B $1B to $5B More than $5B
Reset
Active Market Forge Price1 Last Funding Round Trade Eligibility
Company Sector & Subsector Market Activity4 Highest Bid Lowest Ask Last Matched +/- to LFR $ Total Bids $ Total Asks # Bids # Asks Current Price 6-month 1-year Total Funding Round Date Amount Raised Post-Money Valuation3 Price Key Investors Common Preferred Fund
Solve TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$296.39MMSeries A11/17/2025$296.39MM$426.7MM$4.41Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, Alexandria Venture Investments, AyurMaya Capital Management, DC Global Ventures, Matrix Capital Management, Decheng Capital, General Atlantic, Surveyor Capital
Umoja BiopharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$373.84MMSeries C1/14/2025$100MM$422.45MM$3.95Double Point Ventures, DCVC Bio, ARK Invest, Cormorant Asset Management, MPM Capital, Qiming Venture Partners USA, RTW Investments, Alexandria Venture Investments, SoftBank, CaaS Capital, Emerson Collective, K2 HealthVentures, Myeloma Investment Fund, University of Minnesota
PhlowHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$96.11MMSeries C-17/22/2025$34.88MM$417.6MM$18.09Align Private Capital
IDRxHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$242.24MMSeries B8/7/2024$120.24MM$414.65MM$6.44RA Capital Management, Commodore Capital, Blackstone, Rock Springs Capital, Andreessen Horowitz, Forge Life Science Partners, Nick Lydon, Merck, Nextech Invest
Alamar BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$248.57MMSeries C2/26/2024$128.27MM$409.08MM$2.98Sands Capital, Sherpa Healthcare Partners, Pura Vida Investments
ArteraAIHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$97.32MMSeries Seed-32/1/2024$82.82MM$408.31MM$7.95Coatue, Johnson & Johnson Innovation, Koch Disruptive Technologies, Walden Catalyst, TIME Ventures, Breyer Capital, The Factory, Marc Benioff, Jim Breyer, Lip-Bu Tan, Chris Re, Andy Jacques, Amarjit Gill, Jeff Dean, Steve Blank, Dennis Wong, Clarence So, Michael Driscoll, Prosperity7 Ventures, EDBI, Wilson Sonsini Goodrich & Rosati, Trium Ventures, Navin Chaddha, Rajiv Khemani, Andrew Tan, Elliott Tan
Codiak BioSciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$168.37MMSeries C11/29/2017$76.37MM$404.14MM$3.78ARCH Venture Partners, Flagship Pioneering, Fidelity Management and Research Company, the Alaska Permanent Fund, Alexandria Venture Investments
Verge GenomicsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$167.53MMSeries C*9/8/2023$42MM$403.75MM$7.19Alexion, AstraZeneca, Alumni Ventures, Tenmile
ElektrofiHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$284.44MMSeries C8/8/2024$96.45MM$402.83MM$14.04Undisclosed Investors
AZTherapiesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$121.38MMSeries C-18/28/2020$35MM$401.38MM$6.75Duopharma Biotech Berhad, Spinnaker Capital, ID Fund, DRADS Capital, Wexford Capital, Nextrans-KCLAVIS, Axiom Associates, DEFTA Partners
BiolinqHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$275.18MMSeries C-14/22/2025$100MM$397.31MM$1.05Alpha Wave Ventures, RiverVest Venture Partners, AXA IM Alts, LifeSci Venture Partners, M Ventures, Hikma Ventures, Aphelion Capital, Taisho Pharmaceutical, Features Capital
Seismic TherapeuticHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$470.32MMSeries B12/4/2023$146.28MM$396.35MM$4.52Bessemer Venture Partners, Amgen Ventures, Codon Capital, Alexandria Venture Investments, Gaingels, GC&H, Timothy A. Springer, Lightspeed Venture Partners, Polaris Partners, Boxer Capital, GV, Samsara BioCapital
Clear LabsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$157.08MMSeries D1/13/2025$30MM$395.17MM$2.80Counterpoint Global, Felicis, GV, HBM Genomics, Khosla Ventures, Menlo Ventures, Nimble Ventures, Redmile Group, Wing Venture Capital, T. Rowe Price Associates
Elligo Health ResearchHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$213.37MMSeries E-19/23/2021$34.87MM$392.04MM$1.99Morgan Stanley Expansion Capital, Ally Bridge Group, Norwest Venture Partners, Cerner, Hatteras Venture Partners, Noro-Moseley Partners, Piper Sandler, Shumway Capital, Syneos Health
TenvieHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$200MMSeries A1/8/2025$158.05MM$391.74MM$1.00ARCH Venture Partners, F-Prime Capital, Mubadala Capital
Terray TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$201.97MMSeries B10/17/2024$120MM$386.49MM$6.66Bedford Ridge Capital, NVIDIA, Maverick Capital, Goldcrest Capital, Madrona Venture Group, Two Sigma Ventures, XTX Ventures, Digitalis Ventures, Alexandria Venture Investments
Arthrosi TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$294.54MMSeries E10/8/2025$148.1MM$385.03MM$6.54Prime Eight Capital, CR Biotech, HighLight Capital, HM Venture Partners, ReliantTech
MediBeaconHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$110.73MMSeries 312/7/2023$30.18MM$381.55MM$72.00Undisclosed Investors
AttoviaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$255.85MMSeries C4/15/2025$90MM$378.97MM$1.38Deep Track Capital, Vida Ventures, Sanofi Ventures, Mirae Asset Capital Life Science, Frazier Life Sciences, venBio, Goldman Sachs, Nextech Ventures, Cormorant Asset Management, EcoR1 Capital, Marshall Wace, Illumina Ventures
Prosetta BiosciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$63.64MMSeries D12/31/2015$31.1MM$378.68MM$4.50Takeda Ventures, Alger
ArcellxHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$235.48MMSeries C4/13/2021$120MM$377.76MM$2.10Samsara BioCapital, CAM Capital, Adage, Asymmetry, CaaS Capital, Cambrian Bio, Sixty Degree, Soleus Capital, Surveyor Capital, Suvretta, Terra Magnum Capital Partners, New Enterprise Associates, Novo Holdings, SR One, Takeda Ventures, LG Tech, Clough Capital
TriSalus Life SciencesHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$198.81MMSeries B-210/5/2022$15.32MM$375.88MM$0.35Undisclosed Investors
ArriVent BiopharmaHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$260MMSeries B12/16/2022$110MM$375.08MM$1.05Undisclosed Investors
Bluejay TherapeuticsHealthcare
Biotech & Pharma		Limited$xx.xx$xx.xx$xx.xxxx%$xx.xx$xx.xxxxxxNot available----$242.24MMSeries C-15/9/2024$1.14MM$371.77MM$6.53Frazier Life Sciences, RA Capital Management, T. Rowe Price, Wellington Management, Novo Holdings, RiverVest Venture Partners, Octagon Capital, Arkin Bio Ventures, HBM Healthcare Investments, Unicorn Capital
25-48 of 170

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

  1. Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  2. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.

  3. Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).

  4. Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.

Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.